Search

Recent Articles

IJMPO—A Journey of a Thousand Miles

Author : Padmaj S. Kulkarni

Coronavirus Disease 2019 Treatment—T-Cells Hold the Key in Severe Cases

Author : Kunal Das, Nitika Agrawal, Mansi Kala, Rakhee Khanduri

Why Is China Importing COVID-19 Vaccine Now?

Author : Purvish M. Parikh

Primary B-cell Lymphoblastic Lymphoma of the Ovary

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2018; 39(03): 418-420

DOI: DOI: 10.4103/ijmpo.ijmpo_144_16

Sir,

An 18-year-old unmarried girl presented with a 1-month history of lower abdominal pain without fever, loss of weight or appetite, or menstrual irregularity. At a local hospital, computerised tomography imaging showed a large left adnexal mass measuring 10.6 cm × 7.1 cm × 8.2 cm, for which she underwent laparotomy and ovariectomy and came to us for further management. On evaluation, she had an Eastern Cooperative Oncology Group (ECOG) performance status of one with unremarkable general physical and abdominal examination. The ovariectomy specimen reviewed at our center showed high-grade non-Hodgkin's lymphoma (NHL) confirmed as B-lymphoblastic lymphoma by immunohistochemistry [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]. The malignant cells were positive for LCA, CD20, C79a, CD10, and TdT and negative for staining with LMO, EMA, CD3, and CD68. The Ki-67 was strongly expressed in over 90% of the cells [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]. Serum alpha-fetoprotein (2.09 ng/ml), beta-human chorionic gonadotropin (2.39 mIU/ml), and lactate dehydrogenase levels (381 U/L) were normal. Her baseline hemogram and peripheral smear were normal, and there was no evidence of tumor lysis. Imaging at our center showed no residual tumor in the abdomen. Bone marrow aspiration, bone marrow trephine biopsy, and cerebrospinal fluid analysis were negative for disease involvement. She started systemic therapy as per the Berlin Frankfurt Munster-95 acute lymphoblastic leukemia protocol and remains disease free 2 years after diagnosis.

Figure 1:Sheets of atypical lymphoid cells (H and E, ×400)

Figure.2:Atypical cells show positive reaction for CD45 (DAB, ×400)

Figure.3:Atypical cells show positive reaction for CD79a (DAB, ×400)

Figure.4:Atypical cells show positive reaction for CD10 (DAB, ×400)

Figure.5:Atypical cells show positive reaction for TdT (DAB, ×400)


Ovarian involvement by NHL is rare but is reported to occur either primarily or secondarily.[1],[2] Primary ovarian lymphoma (POL) accounts for 1.5% of all ovarian cancers and 0.5% of all NHLs.[2],[3] The pathogenesis is poorly understood, but the tumor may arise from B- and T-lymphocytes which are found in the ovarian cortex, follicles, or stroma.[4] As per the criteria proposed by Fox et al., ovarian lymphoma is considered to be primary when the tumor burden is confined to the ovary with or without direct lymph nodal infiltration in the adjacent region.[5] Based on this, we diagnosed our patient to have POL.

Most POLs are bilateral and appear homogeneous on imaging.[6] This feature along with the lack of ascites helpful to distinguish them from epithelial ovarian tumors in presurgical scans.[6] There is no consensus on the optimal staging schema for POLs. Both the Ann Arbor and the International Federation of Gynaecology and Obstetrics staging approaches have been used. The major prognostic factors reported are stage at presentation, bilateral versus unilateral disease, tumor size, and International Prognostic Index score >2 and histological subtype.[7]

Among POLs, lymphomas of B-cell origin are the most common with Burkitt's lymphoma and diffuse large B-cell lymphoma accounting for the majority.[4],[8],[9],[10] Primary lymphoblastic lymphoma of the ovary is uncommon but has been reported in the pediatric and adolescent age groups.[11],[12],[13] Acute lymphoblastic leukemia which is biologically similar to lymphoblastic lymphoma has also been reported to involve the ovaries at relapse and can mimic epithelial cancers of the ovary.[14]

This case is being reported for its rarity and to highlight the importance of accurate histopathology in the diagnosis and management of primary ovarian neoplasms. Furthermore, we would like to highlight the possibility of POL in younger patients who present with homogeneous bilateral ovarian masses, without ascites, with normal serum tumor markers and to stress on the requirement for a preoperative biopsy of such ovarian mass lesions. This approach will be effective in preventing unwarranted major surgical resections and thus preserving fertility in such patients; the majority of whom are young and belong to the reproductive age group, as these tumors are exquisitely chemosensitive with good outcomes when treated with chemotherapy alone.

Publication History

Article published online:
17 June 2021

© 2018. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Sir,

An 18-year-old unmarried girl presented with a 1-month history of lower abdominal pain without fever, loss of weight or appetite, or menstrual irregularity. At a local hospital, computerised tomography imaging showed a large left adnexal mass measuring 10.6 cm × 7.1 cm × 8.2 cm, for which she underwent laparotomy and ovariectomy and came to us for further management. On evaluation, she had an Eastern Cooperative Oncology Group (ECOG) performance status of one with unremarkable general physical and abdominal examination. The ovariectomy specimen reviewed at our center showed high-grade non-Hodgkin's lymphoma (NHL) confirmed as B-lymphoblastic lymphoma by immunohistochemistry [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]. The malignant cells were positive for LCA, CD20, C79a, CD10, and TdT and negative for staining with LMO, EMA, CD3, and CD68. The Ki-67 was strongly expressed in over 90% of the cells [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]. Serum alpha-fetoprotein (2.09 ng/ml), beta-human chorionic gonadotropin (2.39 mIU/ml), and lactate dehydrogenase levels (381 U/L) were normal. Her baseline hemogram and peripheral smear were normal, and there was no evidence of tumor lysis. Imaging at our center showed no residual tumor in the abdomen. Bone marrow aspiration, bone marrow trephine biopsy, and cerebrospinal fluid analysis were negative for disease involvement. She started systemic therapy as per the Berlin Frankfurt Munster-95 acute lymphoblastic leukemia protocol and remains disease free 2 years after diagnosis.

Figure 1:Sheets of atypical lymphoid cells (H and E, ×400)

Figure.2:Atypical cells show positive reaction for CD45 (DAB, ×400)

Figure.3:Atypical cells show positive reaction for CD79a (DAB, ×400)

Figure.4:Atypical cells show positive reaction for CD10 (DAB, ×400)

Figure.5:Atypical cells show positive reaction for TdT (DAB, ×400)


Ovarian involvement by NHL is rare but is reported to occur either primarily or secondarily.[1],[2] Primary ovarian lymphoma (POL) accounts for 1.5% of all ovarian cancers and 0.5% of all NHLs.[2],[3] The pathogenesis is poorly understood, but the tumor may arise from B- and T-lymphocytes which are found in the ovarian cortex, follicles, or stroma.[4] As per the criteria proposed by Fox et al., ovarian lymphoma is considered to be primary when the tumor burden is confined to the ovary with or without direct lymph nodal infiltration in the adjacent region.[5] Based on this, we diagnosed our patient to have POL.

Most POLs are bilateral and appear homogeneous on imaging.[6] This feature along with the lack of ascites helpful to distinguish them from epithelial ovarian tumors in presurgical scans.[6] There is no consensus on the optimal staging schema for POLs. Both the Ann Arbor and the International Federation of Gynaecology and Obstetrics staging approaches have been used. The major prognostic factors reported are stage at presentation, bilateral versus unilateral disease, tumor size, and International Prognostic Index score >2 and histological subtype.[7]

Among POLs, lymphomas of B-cell origin are the most common with Burkitt's lymphoma and diffuse large B-cell lymphoma accounting for the majority.[4],[8],[9],[10] Primary lymphoblastic lymphoma of the ovary is uncommon but has been reported in the pediatric and adolescent age groups.[11],[12],[13] Acute lymphoblastic leukemia which is biologically similar to lymphoblastic lymphoma has also been reported to involve the ovaries at relapse and can mimic epithelial cancers of the ovary.[14]

This case is being reported for its rarity and to highlight the importance of accurate histopathology in the diagnosis and management of primary ovarian neoplasms. Furthermore, we would like to highlight the possibility of POL in younger patients who present with homogeneous bilateral ovarian masses, without ascites, with normal serum tumor markers and to stress on the requirement for a preoperative biopsy of such ovarian mass lesions. This approach will be effective in preventing unwarranted major surgical resections and thus preserving fertility in such patients; the majority of whom are young and belong to the reproductive age group, as these tumors are exquisitely chemosensitive with good outcomes when treated with chemotherapy alone.

Conflict of Interest

There are no conflicts of interest.

References

  1. Chorlton I, Norris HJ, King FM. Malignant reticuloendothelial disease involving the ovary as a primary manifestation: A series of 19 lymphomas and 1 granulocytic sarcoma. Cancer 1974; 34: 397-407
  2. Senol T, Doger E, Kahramanoglu I, Geduk A, Kole E, Yucesoy I, Sarin YK, Deshpande VP. Five cases of non-hodgkin B-cell lymphoma of the ovary. Case Rep Obstet Gynecol 2014; 2014: 392758
  3. Dimopoulos MA, Daliani D, Pugh W, Gershenson D, Cabanillas F, Sarris AH. Primary ovarian non-Hodgkin's lymphoma: Outcome after treatment with combination chemotherapy. Gynecol Oncol 1997; 64: 446-50
  4. Vang R, Medeiros LJ, Fuller GN, Sarris AH. Non-Hodgkin's lymphoma involving the gynecologic tract: A review of 88 cases. Adv Anat Pathol 2001; 8: 200-17
  5. Fox H, Langley FA, Govan AD, Hill AS, Bennett MH. Malignant lymphoma presenting as an ovarian tumour: A clinicopathological analysis of 34 cases. Br J Obstet Gynaecol 1988; 95: 386-90
  6. Ferrozzi F, Catanese C, Uccelli M, Bassi P. Ovarian lymphoma. Findings with ultrasonography, computerized tomography and magnetic resonance. Radiol Med 1998; 95: 493-7
  7. Zhao XY, Hong XN, Cao JN, Leaw SJ, Guo Y, Li ZT. et alClinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: A single-center experience. Med Oncol 2011; 28: 1559-64
  8. Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ. Malignant lymphomas involving the ovary A clinicopathologic analysis of 39 cases. Am J Surg Pathol 1993; 17: 154-70
  9. Vang R, Medeiros LJ, Warnke RA, Higgins JP, Deavers MT. Ovarian non-Hodgkin's lymphoma: A clinicopathologic study of eight primary cases. Mod Pathol 2001; 14: 1093-9
  10. Sun J, Zhang J, Ling Q, Luo Y, Wu S, Liang Z. et alPrimary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype. Virchows Arch 2015; 466: 93-100
  11. Sakurai N, Tateoka K, Taguchi J, Terada T. Primary precursor B-cell lymphoblastic lymphoma of the ovary: Case report and review of the literature. Int J Gynecol Pathol 2008; 27: 412-7
  12. Iyengar P, Ismiil N, Deodhare S. Precursor B-cell lymphoblastic lymphoma of the ovaries: An immunohistochemical study and review of the literature. Int J Gynecol Pathol 2004; 23: 193-7
  13. Yadav R, Sharma MC, Karak AK, Agarwal N, Kumar R, Kumar L. Natural history of primary precursor B lymphoblastic lymphoma of the ovary: Report of a rare case. J Obstet Gynaecol Res 2013; 39: 611-6
  14. Singhal MK, Krishnan V, Singh S, Kumar R, Raina V. Isolated ovarian relapse in a 68-year-old woman with acute lymphoblastic leukemia. J Clin Oncol 2010; 28: e73-4

Address for correspondence

Dr. Prasanth Ganesan
Department of Medical Oncology, Cancer Institute (WIA)
Chennai, Tamil Nadu
India   

Publication History

Article published online:
17 June 2021

© 2018. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Figure 1:Sheets of atypical lymphoid cells (H and E, ×400)


Figure.2:Atypical cells show positive reaction for CD45 (DAB, ×400)

Figure.3:Atypical cells show positive reaction for CD79a (DAB, ×400)

Figure.4:Atypical cells show positive reaction for CD10 (DAB, ×400)

Figure.5:Atypical cells show positive reaction for TdT (DAB, ×400)

References

  1. Chorlton I, Norris HJ, King FM. Malignant reticuloendothelial disease involving the ovary as a primary manifestation: A series of 19 lymphomas and 1 granulocytic sarcoma. Cancer 1974; 34: 397-407
  2. Senol T, Doger E, Kahramanoglu I, Geduk A, Kole E, Yucesoy I, Sarin YK, Deshpande VP. Five cases of non-hodgkin B-cell lymphoma of the ovary. Case Rep Obstet Gynecol 2014; 2014: 392758
  3. Dimopoulos MA, Daliani D, Pugh W, Gershenson D, Cabanillas F, Sarris AH. Primary ovarian non-Hodgkin's lymphoma: Outcome after treatment with combination chemotherapy. Gynecol Oncol 1997; 64: 446-50
  4. Vang R, Medeiros LJ, Fuller GN, Sarris AH. Non-Hodgkin's lymphoma involving the gynecologic tract: A review of 88 cases. Adv Anat Pathol 2001; 8: 200-17
  5. Fox H, Langley FA, Govan AD, Hill AS, Bennett MH. Malignant lymphoma presenting as an ovarian tumour: A clinicopathological analysis of 34 cases. Br J Obstet Gynaecol 1988; 95: 386-90
  6. Ferrozzi F, Catanese C, Uccelli M, Bassi P. Ovarian lymphoma. Findings with ultrasonography, computerized tomography and magnetic resonance. Radiol Med 1998; 95: 493-7
  7. Zhao XY, Hong XN, Cao JN, Leaw SJ, Guo Y, Li ZT. et alClinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: A single-center experience. Med Oncol 2011; 28: 1559-64
  8. Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ. Malignant lymphomas involving the ovary A clinicopathologic analysis of 39 cases. Am J Surg Pathol 1993; 17: 154-70
  9. Vang R, Medeiros LJ, Warnke RA, Higgins JP, Deavers MT. Ovarian non-Hodgkin's lymphoma: A clinicopathologic study of eight primary cases. Mod Pathol 2001; 14: 1093-9
  10. Sun J, Zhang J, Ling Q, Luo Y, Wu S, Liang Z. et alPrimary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype. Virchows Arch 2015; 466: 93-100
  11. Sakurai N, Tateoka K, Taguchi J, Terada T. Primary precursor B-cell lymphoblastic lymphoma of the ovary: Case report and review of the literature. Int J Gynecol Pathol 2008; 27: 412-7
  12. Iyengar P, Ismiil N, Deodhare S. Precursor B-cell lymphoblastic lymphoma of the ovaries: An immunohistochemical study and review of the literature. Int J Gynecol Pathol 2004; 23: 193-7
  13. Yadav R, Sharma MC, Karak AK, Agarwal N, Kumar R, Kumar L. Natural history of primary precursor B lymphoblastic lymphoma of the ovary: Report of a rare case. J Obstet Gynaecol Res 2013; 39: 611-6
  14. Singhal MK, Krishnan V, Singh S, Kumar R, Raina V. Isolated ovarian relapse in a 68-year-old woman with acute lymphoblastic leukemia. J Clin Oncol 2010; 28: e73-4
//